| Acronym |
Full Name |
Score |
Rating |
Judge me |
Search |
| PA |
phosphatidic acid |
193 |
8 |
good
bad
|
 |
| PA |
plasminogen activator |
189 |
6 |
good
bad
|
|
| PA |
pulmonary artery |
187 |
-1 |
good
bad
|
|
| PA |
Plasma aldosterone |
55 |
1 |
good
bad
|
|
| PA |
physical activity |
37 |
12 |
good
bad
|
|
| PA |
Pseudomonas aeruginosa |
35 |
11 |
good
bad
|
|
| PA |
particle agglutination |
24 |
11 |
good
bad
|
|
| PA |
primary aldosteronism |
23 |
7 |
good
bad
|
|
| PA |
passive avoidance |
23 |
4 |
good
bad
|
|
| PA |
plasminogen activators |
21 |
22 |
good
bad
|
|
| PA |
pulmonary arteries |
21 |
3 |
good
bad
|
|
| PA |
pulmonary arterial |
20 |
12 |
good
bad
|
|
| PA |
Posteroanterior |
20 |
5 |
good
bad
|
|
| PA |
protective antigen |
19 |
5 |
good
bad
|
|
| PA |
pressure |
18 |
9 |
good
bad
|
|
| PA |
prealbumin |
17 |
17 |
good
bad
|
|
| PA |
platelet aggregation |
17 |
4 |
good
bad
|
|
| PA |
psoriatic arthritis |
16 |
10 |
good
bad
|
|
| PA |
pernicious anaemia |
16 |
2 |
good
bad
|
|
| PA |
puromycin aminonucleoside |
15 |
12 |
good
bad
|
|
| PA |
pleomorphic adenoma |
15 |
9 |
good
bad
|
|
| PA |
aldosterone |
14 |
16 |
good
bad
|
|
| PA |
protein A |
14 |
16 |
good
bad
|
|
| PA |
pyrrolizidine alkaloid |
14 |
12 |
good
bad
|
|
| PA |
palmitic acid |
14 |
7 |
good
bad
|
|
| PA |
procainamide |
12 |
10 |
good
bad
|
|
| PA |
phosphatidate |
12 |
4 |
good
bad
|
|
| PA |
plasma aldosterone concentration |
10 |
10 |
good
bad
|
|
| PA |
phenylacetate |
9 |
5 |
good
bad
|
|
| PA |
Perinatal Asphyxia |
9 |
4 |
good
bad
|
|
| PA |
positive affect |
8 |
8 |
good
bad
|
|
| PA |
propionic acid |
8 |
7 |
good
bad
|
|
| PA |
pulse amplitude |
8 |
3 |
good
bad
|
|
| PA |
propionic acidemia |
8 |
3 |
good
bad
|
|
| PA |
phytic acid |
7 |
15 |
good
bad
|
|
| PA |
plasmapheresis |
7 |
11 |
good
bad
|
|
| PA |
plaque area |
7 |
11 |
good
bad
|
|
| PA |
postero-anterior |
6 |
17 |
good
bad
|
|
| PA |
pantothenic acid |
6 |
8 |
good
bad
|
|
| PA |
pleomorphic adenomas |
5 |
16 |
good
bad
|
|
| PA |
pyrazinoic acid |
5 |
14 |
good
bad
|
|
| PA |
posterior-anterior |
5 |
11 |
good
bad
|
|
| PA |
physician assistant |
5 |
10 |
good
bad
|
|
| PA |
physician assistant |
5 |
10 |
good
bad
|
|
| PA |
prostate-specific antigen |
5 |
8 |
good
bad
|
|
| PA |
pyrrolizidine alkaloids |
5 |
8 |
good
bad
|
|
| PA |
pulmonary artery pressure |
5 |
8 |
good
bad
|
|
| PA |
panic attacks |
5 |
6 |
good
bad
|
|
| PA |
picolinic acid |
5 |
6 |
good
bad
|
|
| PA |
phosphoric acid |
5 |
5 |
good
bad
|
|
| PA |
phthalic anhydride |
5 |
2 |
good
bad
|
|
| PA |
Plasma renin activity (PRA) and aldosterone |
4 |
11 |
good
bad
|
|
| PA |
pulmonary atresia |
4 |
9 |
good
bad
|
|
| PA |
phenylacetic acid |
4 |
9 |
good
bad
|
|
| PA |
pallid |
4 |
8 |
good
bad
|
|
| PA |
premature adrenarche |
4 |
7 |
good
bad
|
|
| PA |
pyloric atresia |
4 |
7 |
good
bad
|
|
| PA |
prostatic antigen |
4 |
4 |
good
bad
|
|
| PA |
pyruvic acid |
4 |
0 |
good
bad
|
|
| PA |
prothrombin activity |
3 |
17 |
good
bad
|
|
| PA |
pyridylamino |
3 |
17 |
good
bad
|
|
| PA |
penicillin acylase |
3 |
15 |
good
bad
|
|
| PA |
phagocytic activity |
3 |
14 |
good
bad
|
|
| PA |
photoacoustic |
3 |
14 |
good
bad
|
|
| PA |
Predictive accuracy |
3 |
14 |
good
bad
|
|
| PA |
particle agglutination assay |
3 |
12 |
good
bad
|
|
| PA |
proteolytic activity |
3 |
12 |
good
bad
|
|
| PA |
phthalic acid |
3 |
11 |
good
bad
|
|
| PA |
polyacrylamide |
3 |
11 |
good
bad
|
|
| PA |
propionic acidaemia |
3 |
10 |
good
bad
|
|
| PA |
paleostriatum augmentatum |
3 |
10 |
good
bad
|
|
| PA |
pressures |
3 |
10 |
good
bad
|
|
| PA |
physical abuse |
3 |
9 |
good
bad
|
|
| PA |
proportions of agreement |
3 |
9 |
good
bad
|
|
| PA |
plasminogen activator activity |
3 |
9 |
good
bad
|
|
| PA |
plicatic acid |
3 |
9 |
good
bad
|
|
| PA |
polyacrylate |
3 |
9 |
good
bad
|
|
| PA |
prostate specific antigen |
3 |
8 |
good
bad
|
|
| PA |
prostate specific antigen |
3 |
8 |
good
bad
|
|
| PA |
peroxidase activity |
3 |
7 |
good
bad
|
|
| PA |
positive affectivity |
3 |
6 |
good
bad
|
|
| PA |
prostate adenocarcinoma |
3 |
6 |
good
bad
|
|
| PA |
Pipemidic Acid |
3 |
3 |
good
bad
|
|
| PA |
Philadelphia |
3 |
3 |
good
bad
|
|
| PA |
protein (RBP) and prealbumin |
2 |
22 |
good
bad
|
|
| PA |
postabsorptive |
2 |
20 |
good
bad
|
|
| PA |
popliteal artery |
2 |
17 |
good
bad
|
|
| PA |
Penitrem A |
2 |
16 |
good
bad
|
|
| PA |
pituitary adenoma |
2 |
16 |
good
bad
|
|
| PA |
postnatal age |
2 |
16 |
good
bad
|
|
| PA |
pyridylaminated |
2 |
15 |
good
bad
|
|
| PA |
pseudoaneurysm |
2 |
14 |
good
bad
|
|
| PA |
pituitary adenomas |
2 |
14 |
good
bad
|
|
| PA |
parasternal intercostal |
2 |
13 |
good
bad
|
|
| PA |
percentage agreement |
2 |
13 |
good
bad
|
|
| PA |
phospholipids and phosphatidic acid |
2 |
12 |
good
bad
|
|
| PA |
paracetamol |
2 |
12 |
good
bad
|
|
| PA |
plasmatic aldosterone |
2 |
12 |
good
bad
|
|
| PA |
proliferation and plasminogen activator |
2 |
12 |
good
bad
|
|
| PA |
posterioanterior |
2 |
11 |
good
bad
|
|
| PA |
preasthma |
2 |
11 |
good
bad
|
|
| PA |
Pancreatic Amylase |
2 |
11 |
good
bad
|
|
| PA |
picoampere |
2 |
11 |
good
bad
|
|
| PA |
pulmonary autograft |
2 |
11 |
good
bad
|
|
| PA |
platelet associated |
2 |
11 |
good
bad
|
|
| PA |
physician assistants |
2 |
10 |
good
bad
|
|
| PA |
promoters |
2 |
10 |
good
bad
|
|
| PA |
paroxysmal activities |
2 |
10 |
good
bad
|
|
| PA |
pituitary-adrenal |
2 |
10 |
good
bad
|
|
| PA |
primary anetoderma |
2 |
9 |
good
bad
|
|
| PA |
Pittsburgh |
2 |
9 |
good
bad
|
|
| PA |
plasminogen activator(s) |
2 |
9 |
good
bad
|
|
| PA |
pullulan acetate |
2 |
8 |
good
bad
|
|
| PA |
prednisolone acetate |
2 |
8 |
good
bad
|
|
| PA |
perillic acid |
2 |
8 |
good
bad
|
|
| PA |
pulmonary arterial pressure |
2 |
8 |
good
bad
|
|
| PA |
protease activation |
2 |
8 |
good
bad
|
|
| PA |
pars anterior |
2 |
7 |
good
bad
|
|
| PA |
penicilloic acid |
2 |
7 |
good
bad
|
|
| PA |
peanut agglutinin |
2 |
7 |
good
bad
|
|
| PA |
phosphatase (PAP) and prostate specific antigen |
2 |
7 |
good
bad
|
|
| PA |
patterned (single) alternation |
2 |
7 |
good
bad
|
|
| PA |
(RV)-pulmonary artery |
2 |
6 |
good
bad
|
|
| PA |
penicillamine |
2 |
6 |
good
bad
|
|
| PA |
permeability-area product |
2 |
6 |
good
bad
|
|
| PA |
permeability-surface area |
2 |
6 |
good
bad
|
|
| PA |
polyamine |
2 |
6 |
good
bad
|
|
| PA |
periodic acid |
2 |
5 |
good
bad
|
|
| PA |
pilocytic astrocytomas |
2 |
5 |
good
bad
|
|
| PA |
phenylacetaldehyde |
2 |
5 |
good
bad
|
|
| PA |
polyacrolein |
2 |
4 |
good
bad
|
|
| PA |
D-penicillamine |
2 |
4 |
good
bad
|
|
| PA |
phytanic acid |
2 |
2 |
good
bad
|
|
| PA |
arterial |
2 |
1 |
good
bad
|
|
| PA |
permeability coefficient of albumin |
2 |
0 |
good
bad
|
|
| PA |
practice are posteroanterior |
1 |
24 |
good
bad
|
|
| PA |
phosphonoacetic acid |
1 |
21 |
good
bad
|
|
| PA |
perception--predictive analysis |
1 |
21 |
good
bad
|
|
| PA |
periodical activity |
1 |
21 |
good
bad
|
|
| PA |
postero-anterior direction |
1 |
21 |
good
bad
|
|
| PA |
Previous asthma |
1 |
20 |
good
bad
|
|
| PA |
pressures reversing anesthesia |
1 |
19 |
good
bad
|
|
| PA |
patients to a placebo group |
1 |
19 |
good
bad
|
|
| PA |
possible anxiety disorder |
1 |
19 |
good
bad
|
|
| PA |
pulmonary adenocarcinomas |
1 |
19 |
good
bad
|
|
| PA |
proliferation and/or polyclonal activation |
1 |
17 |
good
bad
|
|
| PA |
petrous apex |
1 |
17 |
good
bad
|
|
| PA |
passive agglutination test |
1 |
17 |
good
bad
|
|
| PA |
primary and amyloidosis |
1 |
16 |
good
bad
|
|
| PA |
protein A assay |
1 |
16 |
good
bad
|
|
| PA |
pertussis vaccines |
1 |
16 |
good
bad
|
|
| PA |
pneumatic artificial laryngeal |
1 |
16 |
good
bad
|
|
| PA |
pomifera (MPA) but not Arachis hypogaea |
1 |
16 |
good
bad
|
|
| PA |
ploidy and proliferative activity |
1 |
15 |
good
bad
|
|
| PA |
putative messenger phosphatidate |
1 |
15 |
good
bad
|
|
| PA |
periodic abstinence |
1 |
15 |
good
bad
|
|
| PA |
pulmonary aspergillosis |
1 |
15 |
good
bad
|
|
| PA |
peak amplitude of a positive deflection |
1 |
15 |
good
bad
|
|
| PA |
graft-pulmonary artery |
1 |
15 |
good
bad
|
|
| PA |
phosphatidylinositol (PI)-phosphatidic acid |
1 |
15 |
good
bad
|
|
| PA |
pressure (Pc) on changes of arterial |
1 |
15 |
good
bad
|
|
| PA |
paraaortic |
1 |
14 |
good
bad
|
|
| PA |
patients with pancreatic disease |
1 |
14 |
good
bad
|
|
| PA |
proactive aggression |
1 |
14 |
good
bad
|
|
| PA |
pressinoic acid |
1 |
14 |
good
bad
|
|
| PA |
proactivator |
1 |
14 |
good
bad
|
|
| PA |
pulsatile amplitude |
1 |
14 |
good
bad
|
|
| PA |
postapoplectic |
1 |
14 |
good
bad
|
|
| PA |
Plasmin and plasminogen activator |
1 |
14 |
good
bad
|
|
| PA |
permeability-area products |
1 |
14 |
good
bad
|
|
| PA |
Picture Arrangement |
1 |
14 |
good
bad
|
|
| PA |
fragments--phosphatidic acid |
1 |
14 |
good
bad
|
|
| PA |
polyacrylate fiber |
1 |
14 |
good
bad
|
|
| PA |
propionic acids |
1 |
13 |
good
bad
|
|
| PA |
platelet-associated |
1 |
13 |
good
bad
|
|
| PA |
proportion of agreement |
1 |
13 |
good
bad
|
|
| PA |
Pinzgauer x Angus |
1 |
13 |
good
bad
|
|
| PA |
parenteral |
1 |
13 |
good
bad
|
|
| PA |
4-pyridoxic acid |
1 |
13 |
good
bad
|
|
| PA |
plasma aldosterone level |
1 |
13 |
good
bad
|
|
| PA |
plasma aldosterone levels |
1 |
13 |
good
bad
|
|
| PA |
pulmonary |
1 |
13 |
good
bad
|
|
| PA |
pseudomonas |
1 |
13 |
good
bad
|
|
| PA |
proton donor (PD)--proton acceptor |
1 |
13 |
good
bad
|
|
| PA |
particle agglutination test |
1 |
13 |
good
bad
|
|
| PA |
propargyl alcohol |
1 |
13 |
good
bad
|
|
| PA |
promoter upstream of exon 1a |
1 |
13 |
good
bad
|
|
| PA |
permeability-surface area coefficient |
1 |
13 |
good
bad
|
|
| PA |
personal attitude |
1 |
13 |
good
bad
|
|
| PA |
patients and plasma aldosterone |
1 |
13 |
good
bad
|
|
| PA |
phenylalanine |
1 |
13 |
good
bad
|
|
| PA |
poly(anhydrides) |
1 |
13 |
good
bad
|
|
| PA |
plus amikacin |
1 |
13 |
good
bad
|
|
| PA |
physical activity records |
1 |
13 |
good
bad
|
|
| PA |
presence of N omega-phosphoarginine |
1 |
12 |
good
bad
|
|
| PA |
pregnancy |
1 |
12 |
good
bad
|
|
| PA |
posterior adrenalectomy |
1 |
12 |
good
bad
|
|
| PA |
permeation |
1 |
12 |
good
bad
|
|
| PA |
Paired Associates |
1 |
12 |
good
bad
|
|
| PA |
Permeation coefficients |
1 |
12 |
good
bad
|
|
| PA |
penicillin amidase |
1 |
12 |
good
bad
|
|
| PA |
Permeability-surface area product |
1 |
12 |
good
bad
|
|
| PA |
prenatally androgenized |
1 |
12 |
good
bad
|
|
| PA |
pre-albumin |
1 |
12 |
good
bad
|
|
| PA |
periodic activity |
1 |
12 |
good
bad
|
|
| PA |
perinatalasphyxia |
1 |
12 |
good
bad
|
|
| PA |
tcu-plasminogen activator |
1 |
12 |
good
bad
|
|
| PA |
placental artery |
1 |
12 |
good
bad
|
|
| PA |
physiological ages |
1 |
12 |
good
bad
|
|
| PA |
Pseudomonas aeruginosa recA |
1 |
12 |
good
bad
|
|
| PA |
protease and plasminogen activator |
1 |
12 |
good
bad
|
|
| PA |
production of phosphatides |
1 |
12 |
good
bad
|
|
| PA |
pelvic and para-aortic |
1 |
12 |
good
bad
|
|
| PA |
phenyl acetate |
1 |
12 |
good
bad
|
|
| PA |
pseudoaneurisms |
1 |
12 |
good
bad
|
|
| PA |
prehospital analgesia |
1 |
12 |
good
bad
|
|
| PA |
phosphorylase a |
1 |
12 |
good
bad
|
|
| PA |
pelvic area |
1 |
12 |
good
bad
|
|
| PA |
phthalic |
1 |
12 |
good
bad
|
|
| PA |
puncture-aspiration |
1 |
11 |
good
bad
|
|
| PA |
prostatic adenomectomy |
1 |
11 |
good
bad
|
|
| PA |
primary anastomosis |
1 |
11 |
good
bad
|
|
| PA |
[32P]-phosphatidic acid |
1 |
11 |
good
bad
|
|
| PA |
prothrombin activator |
1 |
11 |
good
bad
|
|
| PA |
posteroanterior cephalograms |
1 |
11 |
good
bad
|
|
| PA |
protective activity as protective antigen |
1 |
11 |
good
bad
|
|
| PA |
protective antigens |
1 |
11 |
good
bad
|
|
| PA |
protein (RBP) with prealbumin |
1 |
11 |
good
bad
|
|
| PA |
polyclonal activation |
1 |
11 |
good
bad
|
|
| PA |
pulmonary angiography |
1 |
11 |
good
bad
|
|
| PA |
population-averaged |
1 |
11 |
good
bad
|
|
| PA |
pseudoaneurysms |
1 |
11 |
good
bad
|
|
| PA |
prolonged acting |
1 |
11 |
good
bad
|
|
| PA |
HET-6 |
1 |
11 |
good
bad
|
|
| PA |
phenoxyacetic acid (POA) and phenylacetic acid |
1 |
11 |
good
bad
|
|
| PA |
patients 3-6 sessions of plasmapheresis |
1 |
11 |
good
bad
|
|
| PA |
palmitic |
1 |
11 |
good
bad
|
|
| PA |
parvalbumin |
1 |
11 |
good
bad
|
|
| PA |
phosphoric acid gel |
1 |
11 |
good
bad
|
|
| PA |
phosphoinositides and phosphatidic acid |
1 |
11 |
good
bad
|
|
| PA |
personal assistant |
1 |
11 |
good
bad
|
|
| PA |
Pantoea agglomerans |
1 |
11 |
good
bad
|
|
| PA |
3-dimercapto-1-propanesulfonic acid (DMPS) and D-penicillamine |
1 |
11 |
good
bad
|
|
| PA |
particles |
1 |
11 |
good
bad
|
|
| PA |
PA22-2 |
1 |
11 |
good
bad
|
|
| PA |
paired-associate |
1 |
10 |
good
bad
|
|
| PA |
pulmonary aspergilloma |
1 |
10 |
good
bad
|
|
| PA |
patch abdominoplasty |
1 |
10 |
good
bad
|
|
| PA |
precautionary action |
1 |
10 |
good
bad
|
|
| PA |
paravertebral muscles |
1 |
10 |
good
bad
|
|
| PA |
poly(acrylic acid) |
1 |
10 |
good
bad
|
|
| PA |
possible role of THC-induced pituitary-adrenal |
1 |
10 |
good
bad
|
|
| PA |
phaJ1(Pa) and phaJ2 |
1 |
10 |
good
bad
|
|
| PA |
polysialic acid |
1 |
10 |
good
bad
|
|
| PA |
permeant (K+) ions on polyamine |
1 |
10 |
good
bad
|
|
| PA |
protein aggregate |
1 |
10 |
good
bad
|
|
| PA |
plasminogen activators's |
1 |
10 |
good
bad
|
|
| PA |
pancreatic amylase activity |
1 |
10 |
good
bad
|
|
| PA |
paramethasone acetate |
1 |
10 |
good
bad
|
|
| PA |
perifascicular fiber atrophy |
1 |
10 |
good
bad
|
|
| PA |
portal vein arterialization |
1 |
10 |
good
bad
|
|
| PA |
pregnancy-associated class I antigen |
1 |
10 |
good
bad
|
|
| PA |
Percent |
1 |
10 |
good
bad
|
|
| PA |
progesterone antagonists |
1 |
10 |
good
bad
|
|
| PA |
anti-phospholipid antibodies |
1 |
10 |
good
bad
|
|
| PA |
peak |
1 |
10 |
good
bad
|
|
| PA |
pial arteries |
1 |
10 |
good
bad
|
|
| PA |
proanthocyanidin |
1 |
10 |
good
bad
|
|
| PA |
patient treated with procainamide |
1 |
10 |
good
bad
|
|
| PA |
peak voltage-gated potassium current |
1 |
10 |
good
bad
|
|
| PA |
paraventricular nucleus |
1 |
10 |
good
bad
|
|
| PA |
pentadecaribonucleotide ApUpG(pU)6 |
1 |
10 |
good
bad
|
|
| PA |
proline assay |
1 |
10 |
good
bad
|
|
| PA |
propionic |
1 |
10 |
good
bad
|
|
| PA |
promoter |
1 |
10 |
good
bad
|
|
| PA |
Piliform appendages |
1 |
10 |
good
bad
|
|
| PA |
photoallergic |
1 |
10 |
good
bad
|
|
| PA |
proven human angiostrongyliasis |
1 |
10 |
good
bad
|
|
| PA |
PMA on granule secretion and [32P]-phosphatidate |
1 |
10 |
good
bad
|
|
| PA |
primary amenorrheic |
1 |
9 |
good
bad
|
|
| PA |
Plasminogen activator-like protease |
1 |
9 |
good
bad
|
|
| PA |
post-absorptive |
1 |
9 |
good
bad
|
|
| PA |
PGI2 synthesis in ovine intrapulmonary artery |
1 |
9 |
good
bad
|
|
| PA |
pseudoazurin |
1 |
9 |
good
bad
|
|
| PA |
primary abortion |
1 |
9 |
good
bad
|
|
| PA |
pressure in arterial |
1 |
9 |
good
bad
|
|
| PA |
parthenolide |
1 |
9 |
good
bad
|
|
| PA |
primary antibody |
1 |
9 |
good
bad
|
|
| PA |
paraplegic |
1 |
9 |
good
bad
|
|
| PA |
Paranoia |
1 |
9 |
good
bad
|
|
| PA |
protein (G5P) and d |
1 |
9 |
good
bad
|
|
| PA |
potent antagonist was [D-Phe6]Bn(6-13)propylamide |
1 |
9 |
good
bad
|
|
| PA |
protein (RBP) prealbumin |
1 |
9 |
good
bad
|
|
| PA |
paralbumin |
1 |
9 |
good
bad
|
|
| PA |
paraformaldehyde |
1 |
9 |
good
bad
|
|
| PA |
permeability x area |
1 |
9 |
good
bad
|
|
| PA |
pancreatic adenocarcinoma |
1 |
9 |
good
bad
|
|
| PA |
plasminogen (Plg)/plasminogen activator |
1 |
9 |
good
bad
|
|
| PA |
d(pA)10-d |
1 |
9 |
good
bad
|
|
| PA |
phosphorylase alpha activity |
1 |
9 |
good
bad
|
|
| PA |
palmitoyl ascorbate |
1 |
9 |
good
bad
|
|
| PA |
plasminogen activatory activity |
1 |
9 |
good
bad
|
|
| PA |
phase angle |
1 |
9 |
good
bad
|
|
| PA |
phosphatidic acids |
1 |
9 |
good
bad
|
|
| PA |
phosphate analogs |
1 |
9 |
good
bad
|
|
| PA |
poly(dT)-template and r |
1 |
9 |
good
bad
|
|
| PA |
pulse artifact |
1 |
9 |
good
bad
|
|
| PA |
picolinic acids |
1 |
9 |
good
bad
|
|
| PA |
4%--percutaneous absorption |
1 |
9 |
good
bad
|
|
| PA |
portal vein |
1 |
9 |
good
bad
|
|
| PA |
Pseudomonas aeruginosa exotoxin A |
1 |
9 |
good
bad
|
|
| PA |
phagocytic activities |
1 |
9 |
good
bad
|
|
| PA |
4-pentenoic acid |
1 |
9 |
good
bad
|
|
| PA |
Pseudomonas aeruginosa lipopolysaccharide |
1 |
9 |
good
bad
|
|
| PA |
polyclonal antibodies |
1 |
9 |
good
bad
|
|
| PA |
Porto Alegre |
1 |
9 |
good
bad
|
|
| PA |
pancreatic abscess |
1 |
9 |
good
bad
|
|
| PA |
propofol and alfentanil anesthesia |
1 |
8 |
good
bad
|
|
| PA |
parasternals |
1 |
8 |
good
bad
|
|
| PA |
preinfarction angina |
1 |
8 |
good
bad
|
|
| PA |
positive deflection |
1 |
8 |
good
bad
|
|
| PA |
palaeostriatum augmentatum |
1 |
8 |
good
bad
|
|
| PA |
3H-paroxetine |
1 |
8 |
good
bad
|
|
| PA |
P aeruginosa |
1 |
8 |
good
bad
|
|
| PA |
anthracis-protective antigen |
1 |
8 |
good
bad
|
|
| PA |
Propionibacterium avidum KP-40 |
1 |
8 |
good
bad
|
|
| PA |
performance assessment |
1 |
8 |
good
bad
|
|
| PA |
anti-prostate-specific antigen antibody |
1 |
8 |
good
bad
|
|
| PA |
production of phosphatidate |
1 |
8 |
good
bad
|
|
| PA |
components--protective antigen |
1 |
8 |
good
bad
|
|
| PA |
Phrenic efferent activity |
1 |
8 |
good
bad
|
|
| PA |
passive agglutination |
1 |
8 |
good
bad
|
|
| PA |
pressure assist |
1 |
8 |
good
bad
|
|
| PA |
pressure and plasma aldosterone |
1 |
8 |
good
bad
|
|
| PA |
pentobarbital-anesthetized |
1 |
8 |
good
bad
|
|
| PA |
predicts inhomogeneity of alveolar pressures |
1 |
8 |
good
bad
|
|
| PA |
Pascal |
1 |
8 |
good
bad
|
|
| PA |
pulmonary allograft |
1 |
8 |
good
bad
|
|
| PA |
palmitic acid-1-14C |
1 |
8 |
good
bad
|
|
| PA |
permeability coefficients |
1 |
8 |
good
bad
|
|
| PA |
polyassociated |
1 |
8 |
good
bad
|
|
| PA |
psoriasis with arthritis |
1 |
8 |
good
bad
|
|
| PA |
proteoglycans aggregates |
1 |
8 |
good
bad
|
|
| PA |
Parabrachioamygdaloid |
1 |
8 |
good
bad
|
|
| PA |
Pseudomonas aeruginosa rhlG |
1 |
8 |
good
bad
|
|
| PA |
proton affinities |
1 |
8 |
good
bad
|
|
| PA |
proton-affinity |
1 |
8 |
good
bad
|
|
| PA |
protrusio acetabuli |
1 |
8 |
good
bad
|
|
| PA |
pertussis vaccine |
1 |
8 |
good
bad
|
|
| PA |
phaseic acid |
1 |
8 |
good
bad
|
|
| PA |
palmitate |
1 |
8 |
good
bad
|
|
| PA |
phoneme awareness |
1 |
8 |
good
bad
|
|
| PA |
precipitin antibodies |
1 |
8 |
good
bad
|
|
| PA |
parathyroid adenomas |
1 |
8 |
good
bad
|
|
| PA |
poly(dT)-template and the r |
1 |
8 |
good
bad
|
|
| PA |
phenanthrene |
1 |
8 |
good
bad
|
|
| PA |
preceded by an sigmaA-like promoter |
1 |
8 |
good
bad
|
|
| PA |
peak area |
1 |
7 |
good
bad
|
|
| PA |
pancreatic arterial |
1 |
7 |
good
bad
|
|
| PA |
proximate analysis |
1 |
7 |
good
bad
|
|
| PA |
part of the anterior pretectal nucleus |
1 |
7 |
good
bad
|
|
| PA |
Production Association |
1 |
7 |
good
bad
|
|
| PA |
paroxysmal ataxias |
1 |
7 |
good
bad
|
|
| PA |
primary hyperaldosteronism |
1 |
7 |
good
bad
|
|
| PA |
Pygeum africanum extract (Tadenan) |
1 |
7 |
good
bad
|
|
| PA |
pump-assisted |
1 |
7 |
good
bad
|
|
| PA |
prophylactic antibiotics |
1 |
7 |
good
bad
|
|
| PA |
prophylactic antibiotics orally |
1 |
7 |
good
bad
|
|
| PA |
pronation-abduction |
1 |
7 |
good
bad
|
|
| PA |
protuberic acid |
1 |
7 |
good
bad
|
|
| PA |
Primary Attention |
1 |
7 |
good
bad
|
|
| PA |
prostatic apical |
1 |
7 |
good
bad
|
|
| PA |
Palatal adhesion |
1 |
7 |
good
bad
|
|
| PA |
progressive nonfluent aphasia |
1 |
7 |
good
bad
|
|
| PA |
products apart from phthalic acid |
1 |
7 |
good
bad
|
|
| PA |
predominantly (p)ppA |
1 |
7 |
good
bad
|
|
| PA |
primary aggregation |
1 |
7 |
good
bad
|
|
| PA |
Pollard |
1 |
7 |
good
bad
|
|
| PA |
pretectal nucleus |
1 |
7 |
good
bad
|
|
| PA |
polyarthralgia |
1 |
7 |
good
bad
|
|
| PA |
pes anserinus insersion |
1 |
7 |
good
bad
|
|
| PA |
postaerosolization |
1 |
7 |
good
bad
|
|
| PA |
peptide A |
1 |
7 |
good
bad
|
|
| PA |
Permeability-surface area products |
1 |
7 |
good
bad
|
|
| PA |
peracetic acid |
1 |
7 |
good
bad
|
|
| PA |
postoperative angiography |
1 |
7 |
good
bad
|
|
| PA |
phorbol-13-acetate |
1 |
7 |
good
bad
|
|
| PA |
photon absorptiometry |
1 |
7 |
good
bad
|
|
| PA |
physiological age |
1 |
7 |
good
bad
|
|
| PA |
pilocytic astrocytoma |
1 |
7 |
good
bad
|
|
| PA |
pleural abrasion |
1 |
7 |
good
bad
|
|
| PA |
primary amyloidosis |
1 |
7 |
good
bad
|
|
| PA |
penetrating arterioles |
1 |
7 |
good
bad
|
|
| PA |
plasma adrenaline concentration |
1 |
7 |
good
bad
|
|
| PA |
precocious adrenarche |
1 |
7 |
good
bad
|
|
| PA |
primary alumina |
1 |
7 |
good
bad
|
|
| PA |
posterior-to-anterior |
1 |
6 |
good
bad
|
|
| PA |
pivalic acid |
1 |
6 |
good
bad
|
|
| PA |
P2 and phosphatidic acid |
1 |
6 |
good
bad
|
|
| PA |
protein and protective antigen |
1 |
6 |
good
bad
|
|
| PA |
preadjustment |
1 |
6 |
good
bad
|
|
| PA |
parotid acidic |
1 |
6 |
good
bad
|
|
| PA |
prostate antigen |
1 |
6 |
good
bad
|
|
| PA |
anti-prostate-specific antigen |
1 |
6 |
good
bad
|
|
| PA |
position in the posterior-anterior |
1 |
6 |
good
bad
|
|
| PA |
(C10)-phosphatidic acid |
1 |
6 |
good
bad
|
|
| PA |
paced arithmetic |
1 |
6 |
good
bad
|
|
| PA |
pleural amylase |
1 |
6 |
good
bad
|
|
| PA |
phorbol 13-monoacetate |
1 |
6 |
good
bad
|
|
| PA |
plus and particle agglutination |
1 |
6 |
good
bad
|
|
| PA |
phasic activity |
1 |
6 |
good
bad
|
|
| PA |
polypeptide |
1 |
6 |
good
bad
|
|
| PA |
positive area |
1 |
6 |
good
bad
|
|
| PA |
pertussis vaccine with reduced antigen content |
1 |
6 |
good
bad
|
|
| PA |
postabsorptive state |
1 |
6 |
good
bad
|
|
| PA |
protease activity |
1 |
6 |
good
bad
|
|
| PA |
primary achalasia |
1 |
6 |
good
bad
|
|
| PA |
pressure tracing |
1 |
6 |
good
bad
|
|
| PA |
per annum |
1 |
6 |
good
bad
|
|
| PA |
pemphigus antibodies |
1 |
6 |
good
bad
|
|
| PA |
pressures and pulmonary artery |
1 |
6 |
good
bad
|
|
| PA |
proliferative activity |
1 |
6 |
good
bad
|
|
| PA |
primary aldosteronism caused by aldosteronoma |
1 |
6 |
good
bad
|
|
| PA |
primary angioplasty |
1 |
6 |
good
bad
|
|
| PA |
pepsin activity |
1 |
6 |
good
bad
|
|
| PA |
performance of our EIA with gelatin-particle-agglutination |
1 |
6 |
good
bad
|
|
| PA |
posterior (AP) and posterior to anterior |
1 |
5 |
good
bad
|
|
| PA |
platelet activation |
1 |
5 |
good
bad
|
|
| PA |
peroxidatic activity |
1 |
5 |
good
bad
|
|
| PA |
postalbumin |
1 |
5 |
good
bad
|
|
| PA |
product for nitrite absorption |
1 |
5 |
good
bad
|
|
| PA |
plain acupuncture |
1 |
5 |
good
bad
|
|
| PA |
pyridoxic acid |
1 |
5 |
good
bad
|
|
| PA |
o-phthalic acid |
1 |
5 |
good
bad
|
|
| PA |
polyamines |
1 |
5 |
good
bad
|
|
| PA |
Pretreatment with phosphoramidon |
1 |
5 |
good
bad
|
|
| PA |
Propionibacterium acnes |
1 |
5 |
good
bad
|
|
| PA |
progesterone antagonist |
1 |
5 |
good
bad
|
|
| PA |
3H-phosphatidic acid |
1 |
5 |
good
bad
|
|
| PA |
periapical |
1 |
5 |
good
bad
|
|
| PA |
pterional approach |
1 |
5 |
good
bad
|
|
| PA |
parathyroid adenoma |
1 |
5 |
good
bad
|
|
| PA |
preferential amplification |
1 |
5 |
good
bad
|
|
| PA |
Periplanone-B (PB) and periplanone-A |
1 |
5 |
good
bad
|
|
| PA |
pyrolizidine alkaloid |
1 |
5 |
good
bad
|
|
| PA |
partition analysis |
1 |
5 |
good
bad
|
|
| PA |
pyridine active |
1 |
4 |
good
bad
|
|
| PA |
perceptual asymmetry |
1 |
4 |
good
bad
|
|
| PA |
prior-authorization |
1 |
4 |
good
bad
|
|
| PA |
Pseudomonas aeruginosa strain DGI-R130 |
1 |
4 |
good
bad
|
|
| PA |
pharmacokinetics of D(-)-penicillamine |
1 |
4 |
good
bad
|
|
| PA |
Panama |
1 |
4 |
good
bad
|
|
| PA |
paroxysmal abnormalities |
1 |
4 |
good
bad
|
|
| PA |
penicillic acid |
1 |
4 |
good
bad
|
|
| PA |
Pennsylvania |
1 |
4 |
good
bad
|
|
| PA |
portoarterial |
1 |
4 |
good
bad
|
|
| PA |
paraaortic lymph nodes only |
1 |
4 |
good
bad
|
|
| PA |
pressure of anesthetic in alveolar gas |
1 |
4 |
good
bad
|
|
| PA |
pulvinar |
1 |
4 |
good
bad
|
|
| PA |
5'-acridine/3'-psoralen-oligonucleotide |
1 |
4 |
good
bad
|
|
| PA |
pressure swings |
1 |
4 |
good
bad
|
|
| PA |
peritonsillar abscess |
1 |
4 |
good
bad
|
|
| PA |
pancreaticoduodenal artery |
1 |
4 |
good
bad
|
|
| PA |
primary amenorrhea |
1 |
4 |
good
bad
|
|
| PA |
phosphate |
1 |
4 |
good
bad
|
|
| PA |
physical attractiveness |
1 |
3 |
good
bad
|
|
| PA |
placental amnion |
1 |
3 |
good
bad
|
|
| PA |
picric acid |
1 |
3 |
good
bad
|
|
| PA |
penicillin G amidase |
1 |
3 |
good
bad
|
|
| PA |
plaque assay |
1 |
3 |
good
bad
|
|
| PA |
phosphatase (PAP) and prostatic specific antigen |
1 |
3 |
good
bad
|
|
| PA |
production associations |
1 |
3 |
good
bad
|
|
| PA |
permeability capillary surface area |
1 |
3 |
good
bad
|
|
| PA |
pressione arteriosa |
1 |
3 |
good
bad
|
|
| PA |
potroom asthma |
1 |
3 |
good
bad
|
|
| PA |
powder an phthalic anhydride |
1 |
3 |
good
bad
|
|
| PA |
peripheral artery |
1 |
3 |
good
bad
|
|
| PA |
prostatic adenocarcinoma |
1 |
3 |
good
bad
|
|
| PA |
posterior alveus |
1 |
3 |
good
bad
|
|
| PA |
pharyngeal area |
1 |
3 |
good
bad
|
|
| PA |
parthenogenetic activation |
1 |
3 |
good
bad
|
|
| PA |
practice assessment |
1 |
3 |
good
bad
|
|
| PA |
polyadenylation |
1 |
3 |
good
bad
|
|
| PA |
polymerase |
1 |
2 |
good
bad
|
|
| PA |
plasma aldosterone concentrations |
1 |
2 |
good
bad
|
|
| PA |
trans-pulmonary arteriotomy |
1 |
2 |
good
bad
|
|
| PA |
placental antigen |
1 |
2 |
good
bad
|
|
| PA |
parent artery |
1 |
2 |
good
bad
|
|
| PA |
prior authorization |
1 |
2 |
good
bad
|
|
| PA |
PV and pulmonary artery |
1 |
2 |
good
bad
|
|
| PA |
pentadekaribonukleotida ApUpG(pU)6 |
1 |
2 |
good
bad
|
|
| PA |
perianal abscess |
1 |
2 |
good
bad
|
|
| PA |
Protocol Analysis |
1 |
2 |
good
bad
|
|
| PA |
paraffin agar |
1 |
1 |
good
bad
|
|
| PA |
PGI2-induced contraction in rat intrapulmonary artery |
1 |
1 |
good
bad
|
|
| PA |
MeReO |
1 |
1 |
good
bad
|
|
| PA |
posterior operations |
1 |
0 |
good
bad
|
|
| PA |
parinaric acid |
1 |
0 |
good
bad
|
|
| PA |
peak acceleration |
1 |
0 |
good
bad
|
|
| PA |
pediatric assessment |
1 |
0 |
good
bad
|
|
| PA |
potassium (K) and aldosterone |
1 |
-1 |
good
bad
|
|
| PA |
papular amyloidosis |
1 |
-1 |
good
bad
|
|
| PA |
Polyporic acid |
1 |
-1 |
good
bad
|
|
| PA |
proximal to pallid |
1 |
-1 |
good
bad
|
|